Valneva to provide 40,000 IXCHIQ doses in France starting early April
SE announced earlier that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...
Hosted on MSN5d
Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge
Valneva also has an ongoing license agreement with the Serum Institute of India (SII) to supply its vaccine at an affordable ...
Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“ Valneva ” or the “ Company ”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...
Pharmabiz4d
Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq
Valneva SE, a specialty vaccine company, announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion with its vaccine Ixchiq. In agreement ...
Yahoo Finance6d
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is ...
Morningstar5d
Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F
Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal ...
Yahoo Finance4d
Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Saint-Herblain (France), March 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces that it has filed a ...
Yahoo Finance5d
Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F
Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal Registration ...